arrow
返回
M

Mark M. Zalupski

wayne state university

51H指数
361论文数
1.1W被引数
收录论文 70
发表时间
Characterization of undifferentiated carcinomas of the pancreas with and without osteoclast-like giant cells具有和不具有破骨细胞样巨细胞的胰腺未分化癌的表征
err2024-10-03
err0
errOAAI
errMills, Jamie N.; Gunchick, Valerie; Mcgue, Jake; Qin, Zhaoping; Kumar-Sinha, Chandan; Bednar, Filip; Brown, Noah; Shi, Jiaqi; Udager, Aaron M.; Frankel, Timothy; Zalupski, Mark M.; Sahai, Vaibhav
err分享
err收藏
A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma
err2024-04-01
err0
errOAAI
errEnzler, T.; Nguyen, A.; Misleh, J.; Cline, V. J.; Shumway, N.; Johns, M.; Paulson, S.; Siegel, R.; Larsoni, T.; Messersmithj, W.; Richards, D.; Chaves, J.; Pierce, E.; Zalupski, M.; Sahai, V.; Orr, D.; Ruste, S. A.; Haun, A.; Kawabeo, T.
err分享
err收藏
Analysis of tumor immune microenvironment and clinical outcomes in undifferentiated pancreatic carcinomas with and without osteoclast-like giant cells
err2024-01-16
err0
PREAI
errMills, Jamie N.; Gunchick, Valerie; Shi, Jiaqi; Udager, Aaron; Frankel, Timothy; Zalupski, Mark M.; Sahai, Vaibhav
err分享
err收藏
Multicenter, randomized, parallel group, phase II study to establish the efficacy and safety of CBP501, cisplatin, and nivolumab for I third-line treatment of patients with exocrine pancreatic cancer and WBC <10,000/mm3
err2023-10-01
err1
errOAAI
errEnzler, T.; Nguyen, A.; Misleh, J.; Cline, V. J.; Johns, M. E.; Shumway, N.; Paulson, A. S.; Siegel, R.; Larson, T.; Messersmith, W.; Richards, D.; Chaves, J.; Pierce, E.; Zalupski, M.; Sahai, V.; Orr, D.; Kawabe, T.; Ruste, S. A.; Haun, A.
err分享
err收藏
Genomics driven precision oncology in advanced biliary tract cancer improves survival
err2023-08-01
err3
errOAAI
errKumar-Sinha, Chandan; Vats, Pankaj; Tran, Nguyen; Robinson, Dan R.; Gunchick, Valerie; Wu, Yi-Mi; Cao, Xuhong; Ning, Yu; Wang, Rui; Rabban, Erica; Bell, Janice; Shankar, Sunita; Mannan, Rahul; Zhang, Yuping; Zalupski, Mark M.; Chinnaiyan, Arul M.; Sahai, Vaibhav
err分享
err收藏
Crizotinib (C) in patients (pts) with solid tumors with MET amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
err2023-04-14
err0
PREAI
errMileham, Kathryn F.; Rothe, Michael; Mangat, Pam K.; Garrett-Mayer, Elizabeth; Duvivier, Herbert L.; Calfa, Carmen J.; Dul, Carrie L.; Marr, Alissa S.; Ahn, Eugene R.; Behl, Deepti; Hall, Michael J.; Mehmi, Inderjit; Gaba, Anu; Leidner, Rom; Zalupski, Mark M.; Grantham, Gina N.; Gregory, Abigail; Halabi, Susan; Schilsky, Richard L.
err分享
err收藏
Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials
err2022-08-11
err6
errOAAI
errLedenko, Matthew; Antwi, Samuel O.; Arima, Shiho; Driscoll, Julia; Furuse, Junji; Klumpen, Heinz-Josef; Larsen, Finn Ole; Lau, David K.; Maderer, Annett; Markussen, Alice; Moehler, Markus; Nooijen, Lynn E.; Shaib, Walid L.; Tebbutt, Niall C.; Andre, Thierry; Ueno, Makoto; Woodford, Rachel; Yoo, Changhoon; Zalupski, Mark M.; Patel, Tushar
err分享
err收藏
A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01
errCANCER
IF5.1
err2022-07-27
err40
errOAAI
errSahai, Vaibhav; Griffith, Kent A.; Beg, Muhammad S.; Shaib, Walid L.; Mahalingam, Devalingam; Zhen, David B.; Deming, Dustin A.; Zalupski, Mark M.
err分享
err收藏
A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: The small bowel tumor cohort
err2020-08-15
err2
PREAI
errChae, Young Kwang; Othus, Megan; Patel, Sandip Pravin; Zalupski, Mark; Kasi, Anup; Khalil, Maged; Kalyan, Aparna; Polite, Blase; Fenton, Sarah; Gurung, Sewan; McLeod, Christine M.; Giles, Francis; Chen, Helen X.; Sharon, Elad; Mayerson, Edward; Plets, Melissa; Ryan, Christopher W.; Blanke, Charles D.; Kurzrock, Razelle
err分享
err收藏
Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data基于吉西他滨的可切除胰腺导管腺癌新辅助治疗: 个体患者数据的荟萃分析
err2020-08-11
err12
errOAAI
errGiovinazzo, Francesco; Soggiu, Fiammetta; Jang, Jin-Young; Versteijne, Eva; van Tienhoven, Geertjan; van Eijck, Casper H.; Han, Youngmin; Choi, Seong Ho; Kang, Chang Moo; Zalupski, Mark; Ahmad, Hasham; Yentz, Sarah; Helton, Scott; Rose, J. Bart; Takishita, Chie; Nagakawa, Yuichi; Abu Hilal, Mohammad
err分享
err收藏
Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Cancer
err2020-01-01
err32
errOAAI
errTran, Nguyen H.; Sahai, Vaibhav; Griffith, Kent A.; Nathan, Hari; Kaza, Ravi; Cuneo, Kyle C.; Shi, Jiaqi; Kim, Edward; Sonnenday, Christopher J.; Cho, Clifford S.; Lawrence, Theodore S.; Zalupski, Mark M.
err分享
err收藏
A dose escalation trial of the Wee1 inhibitor AZD1775, in combination with gemcitabine and radiation for patients with locally advanced pancreatic cancer
err2019-07-01
err0
PREAI
errCuneo, Kyle C.; Morgan, Meredith A.; Zalupski, Mark M.; Sahai, Vaibhav; Schipper, Matthew J.; Maybaum, Jonathan; Lawrence, Theodore S.
err分享
err收藏
Prognostic Value of c-MET Expression in Patients With Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy
err2018-02-01
err14
errOAAI
errCuneo, Kyle C.; Morgan, Meredith A.; Griffith, Kent A.; Hawkins, Peter G.; Greenson, Joel K.; Ben-Josef, Edgar; Lawrence, Theodore S.; Zalupski, Mark M.
err分享
err收藏
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitorbinimetinib (MEK162) 的1期剂量递增和扩展研究,一种有效的选择性口服MEK1/2抑制剂
err2017-02-02
err92
errOAAI
errBendell, Johanna C.; Javle, Milind; Bekaii-Saab, Tanios S.; Finn, Richard S.; Wainberg, Zev A.; Laheru, Daniel A.; Weekes, Colin D.; Tan, Benjamin R.; Khan, Gazala N.; Zalupski, Mark M.; Infante, Jeffrey R.; Jones, Suzanne; Papadopoulos, Kyriakos P.; Tolcher, Anthony W.; Chavira, Renae E.; Christy-Bittel, Janna L.; Barrett, Emma; Patnaik, Amita
err分享
err收藏
SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy
err2016-08-20
err2
errOAAI
errDavis, Elizabeth J.; Zhao, Lili; Lucas, David R.; Schuetze, Scott M.; Baker, Laurence H.; Zalupski, Mark M.; Thomas, Dafydd; Chugh, Rashmi
err分享
err收藏
A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer
err2016-07-21
err31
errOAAI
errZhen, David B.; Griffith, Kent A.; Ruch, Joshua M.; Camphausen, Kevin; Savage, Jason E.; Kim, Edward J.; Sahai, Vaibhav; Simeone, Diane M.; Zalupski, Mark M.
err分享
err收藏
A dose escalation trial of the WEE1 inhibitor AZD1775, gemcitabine, and concurrent radiation in locally advanced pancreatic cancer
err2016-07-15
err0
PREAI
errCuneo, Kyle C.; Morgan, Meredith; Schipper, Matthew J.; Maybaum, Jonathan; Feng, Mary U.; Al-Hawary, Mahmoud; Simeone, Diane M.; Olson, Leah D.; Sahai, Vaibhav; Zalupski, Mark; Lawrence, Theodore S.
err分享
err收藏
C-Met and ERCC1 are Prognostic in Patients Receiving Neoadjuvant or Adjuvant Chemoradiation for Pancreatic Cancer
err2015-11-01
err0
PREAI
errCuneo, K. C.; Morgan, M. A.; Zalupski, M. M.; Greenson, J. K.; Schipper, M.; Griffith, K. A.; Ben-Josef, E.; Lawrence, T. S.
err分享
err收藏